CoChat

Protective effect of gut microbiota restored by fecal microbiota transplantation in a sepsis model in juvenile mice

Open access
Han, Young Joo, Kim, SungSu, Shin, Haksup, Kim, Hyun Woo, Park, June Dong · 2024 · Frontiers in Immunology

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Introduction: Restoring a balanced, healthy gut microbiota through fecal microbiota transplantation (FMT) has the potential to be a treatment option for sepsis, despite the current lack of evidence. This study aimed to investigate the effect of FMT on sepsis in relation to the gut microbiota through a sepsis model in juvenile mice. Methods: Three-week-old male mice were divided into three groups: the antibiotic treatment (ABX), ABX-FMT, and control groups. The ABX and ABX-FMT groups received antibiotics for seven days. FMT was performed through oral gavage in the ABX-FMT group over the subsequent seven days. On day 14, all mice underwent cecal ligation and puncture (CLP) to induce abdominal sepsis. Blood cytokine levels and the composition of fecal microbiota were analyzed, and survival was monitored for seven days post-CLP. Results: Initially, the fecal microbiota was predominantly composed of the phyla Bacteroidetes and Firmicutes. After antibiotic intake, an extreme predominance of the class Bacilli emerged. FMT successfully restored antibiotic-induced fecal dysbiosis. After CLP, the phylum Bacteroidetes became extremely dominant in the ABX-FMT and control groups. Alpha diversity of the microbiota decreased after antibiotic intake, was restored after FMT, and decreased again following CLP. In the ABX group, the concentrations of interleukin-1β (IL-1β), IL-2, IL-6, IL-10, granulocyte macrophage colony-stimulating factor, tumor necrosis factor-α, and C-X-C motif chemokine ligand 1 increased more rapidly and to a higher degree compared to other groups. The survival rate in the ABX group was significantly lower (20.0%) compared to other groups (85.7%). Conclusion: FMT-induced microbiota restoration demonstrated a protective effect against sepsis. This study uniquely validates the effectiveness of FMT in a juvenile mouse sepsis model, offering potential implications for clinical research in critically ill children.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2024.1451356

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study design. ABX, antibiotic treatment; CLP, cecal ligation and puncture; FMT, fecal microbiota transplantation.
Figure 1 Study design. ABX, antibiotic treatment; CLP, cecal ligation and puncture; FMT, fecal microbiota transplantation.CC BY · PubMed Central
Figure 2 Composition of fecal microbiota plotted by group and experimental day. (A) Composition of fecal microbiota at the phylum level. (B) Composition of fecal microbiota at the class level. (C) Composition of fecal microbiota at the genus level. (D) Composition of fecal microbiota at the species level. ABX, antibiotic treatment; FMT, fecal microbiota transplantation.
Figure 2 Composition of fecal microbiota plotted by group and experimental day. (A) Composition of fecal microbiota at the phylum level. (B) Composition of fecal microbiota at the class level. (C) Composition of fecal microbiota at the genus level. (D) Composition of fecal microbiota at the species level. ABX, antibiotic treatment; FMT, fecal microbiota transplantation.CC BY · PubMed Central
Figure 3 Relative abundance of each dominant phylum in the fecal microbiota of each group. The bar graph displays the mean values for each group, with error bars representing the mean plus one standard deviation. The y-axis represents the relative abundance of each phylum. (A) Changes in the abundance of each dominant phylum of fecal microbiota over time in each group. (B) Comparison of the relative abundance of each dominant phylum constituting the fecal microbiota on day 7 between each group. (C) Comparison of the relative abundance of each dominant phylum constituting the fecal microbiota on day 14 between each group. ABX: antibiotic treatment, FMT: fecal microbiota transplantation. Asterisks indicate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 with two-tailed Welch’s t-test.
Figure 3 Relative abundance of each dominant phylum in the fecal microbiota of each group. The bar graph displays the mean values for each group, with error bars representing the mean plus one standard deviation. The y-axis represents the relative abundance of each phylum. (A) Changes in the abundance of each dominant phylum of fecal microbiota over time in each group. (B) Comparison of the relative abundance of each dominant phylum constituting the fecal microbiota on day 7 between each group. (C) Comparison of the relative abundance of each dominant phylum constituting the fecal microbiota on day 14 between each group. ABX: antibiotic treatment, FMT: fecal microbiota transplantation. Asterisks indicate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 with two-tailed Welch’s t-test.CC BY · PubMed Central
Figure 4 The Shannon and Simpson’s indices of fecal microbiota. Data are presented as individual values with long and short horizontal bars representing the mean plus one standard deviation. The y-axis represents either the Shannon or Simpson’s indices, depending on the specific panel. (A) Changes in the Shannon and Simpson’s indices for the control group over time. (B) Changes in the Shannon and Simpson’s indices for the ABX-FMT group over time. (C) Changes in the Shannon and Simpson’s indices for the ABX group over time. (D) Comparison of the Shannon or Simpson’s indices of fecal microbiota between each group on day 7 and day 14. ABX, antibiotic treatment; FMT, fecal microbiota transplantation. Asterisks indicate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 with two-tailed Welch’s t-test.
Figure 4 The Shannon and Simpson’s indices of fecal microbiota. Data are presented as individual values with long and short horizontal bars representing the mean plus one standard deviation. The y-axis represents either the Shannon or Simpson’s indices, depending on the specific panel. (A) Changes in the Shannon and Simpson’s indices for the control group over time. (B) Changes in the Shannon and Simpson’s indices for the ABX-FMT group over time. (C) Changes in the Shannon and Simpson’s indices for the ABX group over time. (D) Comparison of the Shannon or Simpson’s indices of fecal microbiota between each group on day 7 and day 14. ABX, antibiotic treatment; FMT, fecal microbiota transplantation. Asterisks indicate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 with two-tailed Welch’s t-test.CC BY · PubMed Central
Figure 5 Beta diversity of the overall fecal microbiota. (A) Non-metric multidimensional scaling plots based on the Bray-Curtis distances for dissimilarity. (B) Non-metric multidimensional scaling plots based on the Euclidean distances for dissimilarity. ABX, antibiotic treatment, D0: day 0, D7: day 7, D14: day 14, D16: day 16, FMT, fecal microbiota transplantation.
Figure 5 Beta diversity of the overall fecal microbiota. (A) Non-metric multidimensional scaling plots based on the Bray-Curtis distances for dissimilarity. (B) Non-metric multidimensional scaling plots based on the Euclidean distances for dissimilarity. ABX, antibiotic treatment, D0: day 0, D7: day 7, D14: day 14, D16: day 16, FMT, fecal microbiota transplantation.CC BY · PubMed Central
Figure 6 Changes in blood cytokine concentrations (pg/ml) in each group from immediately before CLP to 12 hours after. Grey horizontal bars indicate the mean values, and vertical lines represent the mean plus one standard deviation. Sample sizes: n = 7 at all time points in all groups, except for the ABX-FMT group at pre-CLP (n = 5, excluding two subjects due to sample errors). ABX, antibiotic treatment; CLP, cecal ligation and puncture; CXCL1, C-X-C motif chemokine ligand 1; FMT, fecal microbiota transplantation; GM-CSF, granulocyte macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; TNF, tumor necrosis factor. Asterisks indicate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 with two-tailed Welch’s t-test. Colored dotted lines represent comparisons across time within the same group, and solid black lines represent comparisons between groups at the same time.
Figure 6 Changes in blood cytokine concentrations (pg/ml) in each group from immediately before CLP to 12 hours after. Grey horizontal bars indicate the mean values, and vertical lines represent the mean plus one standard deviation. Sample sizes: n = 7 at all time points in all groups, except for the ABX-FMT group at pre-CLP (n = 5, excluding two subjects due to sample errors). ABX, antibiotic treatment; CLP, cecal ligation and puncture; CXCL1, C-X-C motif chemokine ligand 1; FMT, fecal microbiota transplantation; GM-CSF, granulocyte macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; TNF, tumor necrosis factor. Asterisks indicate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 with two-tailed Welch’s t-test. Colored dotted lines represent comparisons across time within the same group, and solid black lines represent comparisons between groups at the same time.CC BY · PubMed Central
Figure 7 Kaplan-Meier survival curve. Sample sizes: n = 5 for the ABX group (two early deaths dropped out), and n = 7 for other groups. ABX, antibiotic treatment; FMT, fecal microbiota transplantation, *p < 0.05.
Figure 7 Kaplan-Meier survival curve. Sample sizes: n = 5 for the ABX group (two early deaths dropped out), and n = 7 for other groups. ABX, antibiotic treatment; FMT, fecal microbiota transplantation, *p < 0.05.CC BY · PubMed Central
Figure 8 Representative histological features from each group showing the extent of infiltration of inflammatory cells. (A) Inflammatory cell infiltration in the lamina propria of the mucosa. (B) Inflammatory cell infiltration in the mesentery, indicating peritonitis. Annotations: neutrophils (thick short arrows), plasma cells (long arrows), macrophages (thick open arrows), and lymphocytes (arrowheads). Staining: H&E. Magnification: ×400; scale bars = 25 µm. ABX, antibiotic treatment; FMT, fecal microbiota transplantation.
Figure 8 Representative histological features from each group showing the extent of infiltration of inflammatory cells. (A) Inflammatory cell infiltration in the lamina propria of the mucosa. (B) Inflammatory cell infiltration in the mesentery, indicating peritonitis. Annotations: neutrophils (thick short arrows), plasma cells (long arrows), macrophages (thick open arrows), and lymphocytes (arrowheads). Staining: H&E. Magnification: ×400; scale bars = 25 µm. ABX, antibiotic treatment; FMT, fecal microbiota transplantation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. 2012, Qiaamp

Cited by

See all 17

Metadata

Authors
Han, Y. J., Kim, S., Shin, H., Kim, H. W., & Park, J. D.
Affiliations
  • Yonsei University (KR)
  • Seoul National University (KR)
Corresponding author
Park, June Dong
Venue
Frontiers in Immunology
Published
2024-10-22
Volume
15
Pages
1451356-1451356
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4403659913
Cited by
17
References
73
Citations by year
2026: 11 · 2025: 6
FWCI
2.31
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Keywords
fecal microbiota transplantation, sepsis, gut microbiota, antibiotic-induced dysbiosis, cecal ligation and puncture, juvenile mice, cytokines, Bacteroidetes, Firmicutes, survival, critically ill children
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Anti-Bacterial Agents, Disease Models, Animal, Feces, Male, Mice, Inbred C57BL, Cytokines, Sepsis, Mice, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protective effect of gut microbiota restored by fecal microbiota transplantation in a sepsis model in juvenile mice. https://app.cochat.ai/papers/10.3389/fimmu.2024.1451356
The paper
Han, Y. J., Kim, S., Shin, H., Kim, H. W., & Park, J. D. (2024). Protective effect of gut microbiota restored by fecal microbiota transplantation in a sepsis model in juvenile mice. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1451356

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.